End-of-day quote
Other stock markets
|
||
- EUR | - |
|
May. 10 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 13 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 |
Chart calendar Laboratorio Reig Jofre SA
Upcoming events on Laboratorio Reig Jofre SA
Past events on Laboratorio Reig Jofre SA
2024-05-16 | Détachement de for Cash amount paid with the scrip issue offered as an alternative to the dividend |
2024-05-08 | Q1 2024 Earnings Call |
2024-05-08 | Q1 2024 Earnings Release Pre-market |
2024-04-11 05:00 am | Extraordinary Shareholders Meeting - Second Call |
2024-04-10 05:00 am | Extraordinary Shareholders Meeting - First Call |
2024-03-13 04:30 am | Q4 2023 Earnings Call |
2024-02-28 | Q4 2023 Earnings Release Pre-market |
2023-10-29 | Q3 2023 Earnings Release Pre-market |
2023-07-26 | Q2 2023 Earnings Release |
2023-05-04 | Détachement de for Cash amount paid with the scrip issue offered as an alternative to the dividend |
2023-03-31 05:00 am | Extraordinary Shareholders Meeting - Second Call |
2023-03-30 05:00 am | Extraordinary Shareholders Meeting - First Call |
2023-03-07 04:00 am | Q4 2022 Earnings Call |
2023-02-27 | Q4 2022 Earnings Release |
2022-10-27 | Q3 2022 Earnings Release |
2022-07-25 | Interim 2022 Earnings Release |
2022-06-14 | Détachement de for Cash amount paid with the scrip issue offered as an alternative to the dividend |
2022-02-27 | FY 2021 Earnings Release Pre-market |
2021-10-28 | Q3 2021 Earnings Release Pre-market |
2021-07-28 | Interim 2021 Earnings Release Pre-market |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 200 203 -1.38% | 0,00 | 236 230 2.71% | 271 264 2.71% | 316 324 -2.44% | 349 |
EBITDA Million EUR | Released Forecast Spread | 19,7 20,9 -5.74% | 0,00 | 27,3 22,0 24.3% | 29,6 26,0 13.83% | 33,7 35,0 -3.84% | 36,6 |
EBIT Million EUR | Released Forecast Spread | 6,32 8,60 -26.48% | 0,00 | 8,86 11,0 -19.43% | 8,53 13,0 -34.37% | 10,5 15,0 -29.93% | 13,6 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 5,30 7,60 -30.22% | 0,00 | 5,79 8,00 -27.59% | 8,76 7,00 25.2% | 10,5 16,0 -34.4% | 13,2 |
Net income Million EUR | Released Forecast Spread | 4,94 6,70 -26.24% | 5,67 | 5,09 6,00 -15.13% | 8,11 5,00 62.14% | 9,41 13,0 -27.64% | 11,3 |
EPS EUR | Released Forecast Spread | 0,07 0,09 -22.22% | 0,08 | 0,07 0,08 -12.5% | 0,10 0,07 42.86% | 0,12 0,17 -29.41% | 0,14 |
Announcement Date | 02/03/20 | 26/02/21 | 28/02/22 | 28/02/23 | 29/02/24 | - |
Past sector events for Laboratorio Reig Jofre SA
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
- Stock Market
- Equities
- RJF Stock
- Stock
- Calendar Laboratorio Reig Jofre SA